PERTZYE

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Cystic FibrosisPancreatic Ductal Adenocarcinoma

107 competitors in Cystic Fibrosis

#DrugCompanyPhaseTrials

1

Ibsrela

AArdelyx

Phase 3

12

Biaxin

AbbVie

Phase 2

23

Mycobutin

Pfizer

Phase 2

14

Lamprene

Novartis

Phase 2

15

HSK31858

Haisco Pharmaceutical Group Co., Ltd.

Phase 3

26

ELX/TEZ/IVA

Vertex Pharmaceuticals

Phase 3

187

Trikafta

NNottingham University Hospitals NHS Trust

Phase 3

48

VNZ/TEZ/D-IVA

Vertex Pharmaceuticals

Phase 3

19

VX-121/TEZ/D-IVA

Vertex Pharmaceuticals

Phase 3

410

Verapamil Hydrochloride

Mylan Pharmaceuticals Inc

Phase 3

1Show 33 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Cystic Fibrosis1 trial

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Terminated·AbbVie··NCT01652157·17 enrolled

Pancreatic Ductal Adenocarcinoma1 trial

Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)

Active, not recruiting·MMemorial Sloan Kettering Cancer Center·Phase 1/2·NCT05642962·17 enrolled

Pancreatic1 trial

A Study to Determine the Prevalence of Exocrine Pancreatic Insufficiency (EPI) in Pediatric and Adult Participants With Alagille Syndrome After Liver Transplantation

Recruiting·DDigestive Care, Inc.··NCT07335523·30 enrolled

Details

Drug Info

Related News